

The company develops cell therapies for life-threatening liver failure using human iPS cell-derived liver progenitor cells.
#
Healthcare
お知らせ
NEWS
No Content


The company develops cell therapies for life-threatening liver failure using human iPS cell-derived liver progenitor cells.
#
Healthcare
NEWS
No Content
© One Capital lnc.